NCT00095446View on ClinicalTrials.gov

NovoLog Observation Trial in Subjects With Type 1 and Type 2 Diabetes

PHASE4CompletedINTERVENTIONAL

Enrollment

513

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

March 31, 2005

Study Completion Date

March 31, 2005

Conditions

DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2

Interventions

DRUG

insulin aspart

Trial Locations (1)

08540

Novo Nordisk Investigational Site, Princeton

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY

NCT00095446 - NovoLog Observation Trial in Subjects With Type 1 and Type 2 Diabetes | Biotech Hunter | Biotech Hunter